Susquehanna International Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26.3M | Buy |
|
|||||
|
2025
Q2 | $16.2M | Buy |
|
|||||
|
2025
Q1 | $10.8M | Buy |
|
|||||
|
2024
Q4 | $11.3M | Buy |
|
|||||
|
2024
Q3 | $7.05M | Sell |
|
|||||
|
2024
Q2 | $10.2M | Buy |
|
|||||
|
2024
Q1 | $8.31M | Buy |
|
|||||
|
2023
Q4 | $3.59M | Buy |
|
|||||
|
2023
Q3 | $2.35M | Buy |
|
|||||
|
2023
Q2 | $730K | Sell |
|
|||||
|
2023
Q1 | $1.36M | Buy |
|
|||||
|
2022
Q4 | $478K | Sell |
|
|||||
|
2022
Q3 | $916K | Buy |
|
|||||
|
2022
Q2 | $224K | Sell |
|
|||||
|
2022
Q1 | $378K | Sell |
|
|||||
|
2021
Q4 | $3.52M | Buy |
|
|||||
|
2021
Q3 | $2.7M | Buy |
|
|||||
|
2021
Q2 | $1.85M | Buy |
|